English | Español

Eli Lilly And Company
+ Regulatory
Carol Ostrow | Oct 14, 2017

Lilly wins right to patent Alimta vitamin treatment for certain lung cancers
+ Technology/Innovation
Carrie Bradon | Sep 21, 2017

Oncology Data Network called key to improving health care in Europe
+ Technology/Innovation
Carol Ostrow | Sep 20, 2017

Lilly study supports Cyramza (ramucirumab) efficacy for treating urothelial carcinoma
+ Regulatory
Carrie Bradon | Jul 9, 2017

Japanese Ministry of Health, Labor and Welfare approves Olumiant
+ Technology/Innovation
Erianne Leatherman | Jun 21, 2017

Lilly says its galcanezumab cuts down on amount of migraine headache days
+ Technology/Innovation
Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
+ Technology/Innovation
Robert Hadley | Jun 14, 2017

Eli Lilly anti-cancer drug may halt breast cancer spread when paired with fulvestrant
+ Technology/Innovation
Ruth de Jauregui | May 21, 2017

Lilly says studies show galcanezumab can reduce migraine episodes

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes